(Reuters) — Abbott Laboratories Inc. said it settled a lawsuit related to the sale of its cholesterol-lowering formulations and would pay about $184 million to resolve the claims. Abbott shares fell as much as 5 percent in afternoon trade. In a regulatory filing, Abbott said it plans to ...
